Henry Kissinger, Bill Gates, and other luminaries steer a little-known organization that favors exploring a trade pact
The point of a draft is to help the worst teams get better, but the lottery pits the worst teams against the merely mediocre
Startup TrackingPoint sells a rifle with laser and computer technology that lets a novice hit moving targets 500 yards distant—then post the kill online
To extend Internet access throughout the world, Google may be working on balloon-based broadband transmitters
Helped by the Fed, it's very cheap to borrow money. This could end badly
Farmers reported their progress via Twitter and Instagram, using hashtags like #plant13
The film director has a site selling movie-themed T-shirts and memorabilia, as well as promoting a Bolivian liquor
George Washington University is planning a series of undergraduate programs in marketing, international business, and, starting this fall, finance
The West's housing rebound is helping small companies while delinquency rates remain higher along the Eastern seaboard, says a new report
Founders: Dr. Mark Chandler and Craig Benson (The company was formed in 1998 as a wholly owned subsidiary of Luminex Corp. (LMNX) and subsequently spun off in 2002 as a private management-owned entity.)
VC Investment over the last four quarters: $25 million
With 95 employees worldwide, Rules-Based Medicine, a biomarker testing company, is actively developing diagnostic tests to detect the presence of complex diseases and conditions in the areas of neuropsychiatry, nephrology, immunology, and cardiology. The company is also developing what it calls the first fully closed reproducible whole-blood culture system. Despite the recession, Rules-Based Medicine's founders remain optimistic about its prospects and those of its peers that promote efficiency and cost savings for drug development and diagnostics customers.
Key to startup success: "We took a customer-focused approach to biotechnology, which drove our decision to commit resources to developing much needed comprehensive biomarker content. ... Our customers have essentially directed and funded our R&D since inception."